SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-12-024004
Filing Date
2012-04-26
Accepted
2012-04-26 15:13:03
Documents
1
Period of Report
2012-04-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v310761_3.html 3  
1 OWNERSHIP DOCUMENT v310761_3.xml 3 1512
  Complete submission text file 0001144204-12-024004.txt   3149
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XTL BIOPHARMACEUTICALS LTD 711 EXECUTIVE BLVD., SUITE Q VALLEY COTTAGE NY 10989
Business Address
KENNEDY WILLIAM JAMES (Reporting) CIK: 0001448888 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32639 | Film No.: 12783166